Lv5
1016 积分 2024-06-25 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
1个月前
已完结
Performance of small-scale CHO perfusion cultures using an acoustic cell filtration device for cell retention: Characterization of separation efficiency and impact of perfusion on product quality
3个月前
已完结
Metal-doping engineering-driven STING-PANoptosis cascade for enhanced cancer sono-immunotherapy
9个月前
已完结
皖公网安备34019202002308
